CeriBell Maps 2026 Growth at JPMorgan MedTech, Eyes Delirium and Stroke EEG Expansion [Yahoo! Finance]
CeriBell, Inc. (CBLL)
Company Research
Source: Yahoo! Finance
The neuromonitoring platform uses a disposable headband and phone-sized recorder with AI engine Clarity to enable ~5-minute bedside EEG and continuous analysis; the retrospective SAFER study (~1,000 patients) found conventional EEG arrived ~ 19 hours later and Ceribell use was associated with a 4.1-day shorter ICU stay and a drop in severe disability at discharge from to 2026 priorities focus on scaling sales productivity and utilization, securing FedRAMP High access to ~160 VA hospitals, and commercializing new indications—notably the company's claim of the first FDA-cleared delirium detection tool with a market pilot in 2026 and a planned full launch in Q4 2026/early 2027 (plus NTAP and large-vessel occlusion breakthrough opportunities). Interested in CeriBell, Inc.? Here are five stocks we like better. CeriBell (NASDAQ:CBLL) outlined its recent progress and 2026 priorities at a JPMorgan MedTech event, emphasizing continued growth in acute-care seizure detection and an expand
Show less
Read more
Impact Snapshot
Event Time:
CBLL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CBLL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CBLL alerts
High impacting CeriBell, Inc. news events
Weekly update
A roundup of the hottest topics
CBLL
News
- Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution [Yahoo! Finance]Yahoo! Finance
- Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring SolutionGlobeNewswire
- Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- CeriBell (NASDAQ:CBLL) had its price target raised by analysts at Canaccord Genuity Group Inc. from $29.00 to $30.00. They now have a "buy" rating on the stock.MarketBeat
- CeriBell (NASDAQ:CBLL) had its "buy" rating reaffirmed by analysts at BTIG Research.MarketBeat
CBLL
Earnings
- 11/4/25 - Beat
CBLL
Sec Filings
- 1/15/26 - Form 144
- 1/12/26 - Form 4
- 1/7/26 - Form 4
- CBLL's page on the SEC website